Durability and Lifetime Management of the Avalus™ Platform

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/d9/dc/0d/d9dc0d2a-e54a-6521-dbe2-c6ec8e5dfc44/mza_11703460016194122313.jpg/600x600bb.jpg

The Cardiac Exchange

Medtronic

45 episodes

1 month ago

A podcast series from Medtronic that goes straight to your ears to your heart. Join cardiac surgery professionals as they discuss recent developments in patient care, advancements in therapy technology and share personal experiences.

Medicine

Health & Fitness

RSS

All content for The Cardiac Exchange is the property of Medtronic and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

Durability and Lifetime Management of the Avalus™ Platform

The Cardiac Exchange

45 minutes

1 month ago

Durability and Lifetime Management of the Avalus™ Platform

Professor Kappetein sits down with Mr Dincer Aktuerk of Barts Heart Center in London, United Kingdom and Professor Robert Klautz of Leiden University Medical Center, Netherlands to discuss the clinical data from the PERIGON Study. This discussion covers a variety of topics including the importance of data when treating patients, with a focus on lifetime management and durability of surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) surgeries.1

1. Sabik JF III, Rao V, Dagenais F, et al. 7-Year outcomes after surgical aortic valve replacement with a stented bovine pericardial bioprosthesis in over 1100 patients: a prospective multicenter analysis. Eur J Cardiothorac Surg. 2024;67(1):ezae414. doi:10.1093/ejcts/ezae414.

Statements based on physician experience. Individual results may vary. Physicians are paid consultants of Medtronic.

See Avalus™ Bioprosthesis risk information: https://www.medtronic.com/en-us/healthcare-professionals/products/cardiovascular/heart-valves/tissue-valves-conduits/avalus-bioprosthesis.html?sheet=open